Simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma using high-performance liquid chromatography

被引:14
作者
Carlucci, G [1 ]
Mazzeo, P [1 ]
Palumbo, G [1 ]
机构
[1] UNIV LAQUILA,CATTEDRA FARMACOL,DIPARTIMENTO MED INTERNA & SANITA PUBBL,I-67100 LAQUILA,ITALY
来源
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 1996年 / 682卷 / 02期
关键词
rufloxacin; fenbufen; felbinac;
D O I
10.1016/0378-4347(96)00073-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, specific and sensitive high-performance liquid chromatographic method has been developed for the simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma. Plasma, spiked with internal standard, was vortex-mixed for 1 min with a mixture of dichloromethane-diethyl ether (80:20, v/v). The evaporated extract was dissolved in 0.02 M NaOH. Drugs were resolved at room temperature on a 5 mu m Zorbax SAX column (250X4.6 mm I.D.) equipped with a 20X4.6 mm anion-exchange Vydac AXGU (10 mu m particle size) precolumn. The mobile phase consisted of acetonitrile and phosphate buffer (pH 7.0): delivered at a flow-rate of 1.2 ml/min. Detection was made at 280 nm. 2-[4-(2'-Furoyl)phenyl]propionic acid was used as internal standard. The calibration curve was linear from 0.2 to 10 mu g/ml for rufloxacin, from 0.5 to 30 mu g/ml for fenbufen and from 0.2 to 10 mu g/ml for felbinac, respectively. The detection limit was 0.1 mu g/ml for rufloxacin, 0.3 mu g/ml for fenbufen and 0.1 mu g/ml for felbinac, respectively.
引用
收藏
页码:315 / 319
页数:5
相关论文
共 10 条
[1]   ANALYTICAL PROCEDURE FOR THE DETERMINATION OF RUFLOXACIN, A NEW PYRIDOBENZOTHIAZINE, IN HUMAN SERUM AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
CARLUCCI, G ;
PALUMBO, G .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 564 (01) :346-351
[2]  
CHICCARELLI FS, 1980, ARZNEIMITTEL-FORSCH, V30-1, P728
[3]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ASSAY FOR FENBUFEN AND 2 SERUM METABOLITES [J].
FLEITMAN, JS ;
SCHULMAN, SG ;
PERRIN, JH .
JOURNAL OF CHROMATOGRAPHY, 1982, 228 (MAR) :372-376
[4]  
HORI S, 1989, REV INFECT DIS, V11, pS1397
[5]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF RUFLOXACIN AND ITS MAIN ACTIVE METABOLITE IN BIOLOGICAL-FLUIDS [J].
LOMBARDI, F ;
ARDEMAGNI, R ;
COLZANI, V ;
VISCONTI, M .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 576 (01) :129-134
[6]  
*MIN HLTH WELF, 1986, INF DRUG ADV REACT, V81, P1
[7]  
NIX DE, 1987, CLIN PHARMACY, V6, P105
[8]  
SEGRE G, 1988, DRUG EXP CLIN RES, V14, P747
[9]  
SLOBODA AE, 1980, ARZNEIMITTEL-FORSCH, V30-1, P716
[10]   QUANTITATION OF ANTI-INFLAMMATORY AGENT FENBUFEN AND ITS METABOLITES IN HUMAN-SERUM AND URINE USING HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
VANLEAR, GE ;
CHICCARELLI, FS ;
BONENFANT, PA ;
BARR, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (12) :1662-1664